TPG Biotech Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 3
Professionals
  • Investments
  • 170
  • Portfolio
  • 22
  • Exits
  • 72
Exits

TPG Biotech General Information

Description

Founded in 2002, TPG Biotech is a venture capital arm of TPG Capital based in San Francisco, California. The firm prefers to invest in medical technology, therapeutic, healthcare service, industrial biotechnology, life science, and medical device sectors.

Contact Information

Year Founded
2002
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • 345 California Street
  • Suite 3300
  • San Francisco, CA 94104
  • United States
+1 (415) 000-0000

TPG Biotech Investments (170)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Azura Ophthalmics 22-Oct-2020 Later Stage VC 0000 Drug Discovery Clinical Trials - Phase 2
0000000 0000000000 08-Jul-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1 0000 00000 00.0
0000000 26-May-2020 00000 00000 0000 Drug Discovery Clinical Trials - General 00000 0000000 00.0
000000 24-Apr-2020 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2
0000000 0000000000 24-Apr-2019 00000 00000 0000 Pharmaceuticals Generating Revenue/Not Profitable 00000 0000000 00.0
000000 00000000000 25-Mar-2019 00000 00000 00000 Drug Discovery Clinical Trials - Phase 1 0000 00000 00.0
00000000 06-Feb-2019 00000 00000 0000 Other Healthcare Technology Systems Generating Revenue 00000000 0000 00.0
00000 000000000000 05-Sep-2018 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2 0000 00000 00.0
Elevance Renewable Sciences 11-Jun-2018 Later Stage VC 000.00 Specialty Chemicals Generating Revenue 00000000 0000 00.0
Halo (Therapeutic Devices) 30-May-2018 Early Stage VC 000.00 Therapeutic Devices Generating Revenue 00000 0000000 00.0
You’re viewing 10 of 170 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TPG Biotech Exits (72)

Company Name Exit Date Exit Type Exit Size
Fusion Pharmaceuticals 26-Jun-2020 IPO 00000
0000000 0000000000 12-Jun-2020 000 00000
000000 00000000000 05-Jun-2020 000000000000000000 00000
00000000 01-May-2020 000 00 00000000
0000000 25-Oct-2019 000 00000
0000000 0000000000 13-Sep-2019 000 000.00
0000000 02-Aug-2019 0000000000: 000000
00000 000000000000 07-May-2019 000 0000
Galleon Pharmaceuticals 01-Feb-2019 Out of Business
CardioDx 09-Jan-2019 Out of Business
You’re viewing 10 of 72 exits. Get the full list »

TPG Biotech Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

TPG Biotech Team (13)

Name Title Deals Funds Boards Office
Peter Bojo Associate San Francisco, CA
Eran Nadav Ph.D Partner & Managing Director 00 0 0 San Francisco, CA
You’re viewing 2 of 13 team members. Get the full list »

TPG Biotech Co-Investors (97)

Name With Exits Lead Partner Series Industry
Lumira Ventures 3 0 0 Series chart Industry bar
Nan Fung Life Sciences 0 0 Series chart Industry bar
Novo Holdings 0 0 Series chart Industry bar
OrbiMed 0 0 0 Series chart Industry bar
Claremont Creek Ventures 0 0 0 Series chart Industry bar
You’re viewing 5 of 97 co-investors. Get the full list »